Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
|
Identify the anterior pituitary gland hormones that influence the female and male reproductive systems:
|
[McKenry pg 883]
FSH - Follicle Stimulating Hormone LH - Luteinizing Hormone aka: ICSH - Interstitial Cell-Stimulating Hormone |
|
|
Describe hormonal influences on uterine function during the menstrual cycle:
[McKenry pg 883 & Fig 51-2 on pg 885] |
Day 1 (Onset) thru Day 5 (End):
FSH => follicular growth in ovary. Ovary => Estrogen. Estrogen increases, FSH decreases. PROLIFERATION STAGE OF THE UTERUS - Estrogen levels increase, preparing uterus for fertilized ovum: 1- Growth of endometrium lining uterus. 2- Production of endocervical glands with nutrients for sperm. |
|
|
Identify the primary male and female hormones:
|
look up
|
|
|
Describe the effects of estrogen and progesterone during the proliferation stage:
|
look up
|
|
|
Trace the transport of sperm in the male body from production to ejaculation.
|
look up
|
|
|
ANDROGEN
[McKenry pg 883] MALE reproductive hormone |
pg 883
|
|
|
ESTROGEN
One of the two main types of Female Sex Hormones secreted by the Ovary. |
pg 883
|
|
|
FOLLICLE-STIMULATING HORMONE(FSH)
[McKenry pg 883] In the Female: FSH stimulates the growth & maturation of GRAAFIAN follicles in the OVARY. In the Male: FSH stimulates the development of the seminiferous tubules and promotes spermatogenisis in the Testes. |
pg 883
|
|
|
LUTEINIZING HORMONE (LH)
[McKenry pg 883] aka: Interstitial Cell-Stimulating Hormone (ICSH) In the Female: LH / ICSH promotes the growth of the Interstitial cells in the follicle and the formation of the Corpus Luteum. In the Male: LH / ICSH stimulates the growth of Interstitial cells in the testes & promotes the formation of the hormone androgen (testosterone). |
pg 883
|
|
|
OVULATION
[McKenry pg 883] DAY 14: Ovulation occurs when the matre follicle ruptures and releases its ovum. The ovum travels through the fallopian tube to the uterus. |
pg 883
|
|
|
progestogen
|
pg 883
|
|
|
testosterone
|
pg 885
|
|
|
Describe the source and action of chorionic gonadotropin:
|
look up
|
|
|
Discuss the function of the primary female sex hormones:
|
look up
|
|
|
Discuss the side effects/adverse reactions of estrogens and progestins:
|
look up
|
|
|
Compare and contrast monphasic, biphasic, and triphasic oral contraceptives:
|
look up
|
|
|
Implement the nursing management for the care of clients receiving drug therapy affecting the female reproductive system.
|
look up
|
|
|
ANOVULATION
[McKenry pg 904] The ABSENCE of OVULATION. |
Physiologic in pregnant, breastfeeding, or postmenopausal women.
Suspected pathologic in women with abnormal bleeding or infertility. Clomiphene & urofollitropin are ovulation stimulants used to treat infertility in the female. |
|
|
BIPHASIC ORAL CONTRACTEPTIVES
One of Three types of combination estrogen & progestin contraceptives. BIPHASIC oral contracetion supplies Two different amounts of PROGESTIN during the FIRST & SECOND phases of the menstrual cycle. Low levels of progestin are administered in the FOLLICULAR phase (1st 7 to 10 days) and are increased during the next 11 to 14 days of the LUTEAL phase. The 28-day biphasic cycle has placebo tablets of a third color to mark clearly the proper sequence and reduce any possibility of confusion. |
pg 898
|
|
|
MONOPHASIC ORAL CONTRACEPTIVES:
One of Three types of Combination estrogen and progestin contraceptives. Monophasic oral contraception is a FIXED RATIO of estrogen & progestin that is taken for 21 days of the normal menstrual cycle. |
pg 898
|
|
|
ORAL CONTRACEPTIVES:
Most Effective birth control type. New Lower-dose oral contraceptives have: Lower Cardiovascular risk. Increased MI risk (smokers & 35yrs+). Lower risk: Stroke/Thromboembolic disease than other types. Decreased rate of Ectopic Pregnancy. Decreased risk: Ovarian Cyst, Endometrial Ovarian CA, & Endometrial CA. Increased risk: Cervical CA, Liver CA, & earlier onset Breast CA (long-term). |
[McKenry pg 897]
|
|
|
PROGESTOGENS
[McKenry pg 893] One of the two main types of Female Sex Hormones secreted by the Ovary. Progestogens are luteal or progestational hormones derived from the corpus luteum that is formed in the ovary from the ruptured follicle. |
pg 893
|
|
|
TRIPHASIC
ORAL CONTRACEPTION [McKenry pg 900] Most closely simulates the normal estrogen and progesterone levels during the menstrual cycle. Lowest possible doses of hormones used = decreased incidence & severity of adverse reactions. |
Ortho-Novum 7/7/7
Triphasil & Orhto Tri-Cyclen |
|
|
PROGESTIN
[McKenry pg 896] Tx of Female Hormonal Imbalance: amenorrhea, dysmenorrhea, endometriosis, & specific carcinomas. Also used tp Dx emdpgempis estrpgem defocoemcu & to prevent pregnancy. Combined with estrogen to lower risk of breast & endometrial CA w/ hormone replacement therapy. |
Progesterone & progestins (hydroxyprogesterone, norethindrone)
=> biochemical changes in the endometrium Prepare for implant & nourishment of embryo. Supplement estrogen effect on uterus & mammory glands Suppress ovulation (in pregnancy) Relax smooth muscle of uterus Increase DNA & RNA synthesis Inhibit the secretion of LH from ant. pit. |
|
|
Drugs affecting the female reproductive system include:
[McKenry ch 52 pg 889] |
GnRH: GONADOTROPIN-RELEASING Hormones
NONPITUITARY CHORIONIC GONADOTROPINS MENOTROPINS FEMALE SEX HORMONES ORAL CONTRACEPTIVES OVULATORY STIMULANTS & INFERTILITY DRUGS. |
|
|
Chloasma
[Taber's pg 400] |
Tan to brown, sharply defined PATCHES of SKIN PIGMENT, usually found symmetrically on the forehead, temples, cheeks, or upper lip.
The excess pigmentation often occurs in pregnant women, in women using ORAL CONTRACEPTIVES, or in patients with underlying liver disease. Women are more affected than men. Sun exposure tends to worsen the condition, |
